Verification evidence is still being completed.
PDF / print export
CARBOGEN AMCIS
Bubendorf, Switzerland
- Verified lead
- Stephan Fritschi
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CDMO, Drug Substance Development, Drug Product Manufacturing, Small Molecules, and Biologics
- Review cycle
- May 2026
- Full address
- Emdpark, 4416 Bubendorf, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official CARBOGEN AMCIS contact page confirming the Bubendorf address.
- Editorial note
- CARBOGEN AMCIS is published because official company materials confirm current leadership, a real Swiss operating address, and a substantial CDMO manufacturing footprint.
CDMO, Drug Substance Development, Drug Product Manufacturing, Small Molecules, and Biologics
Official leadership disclosure, Official Swiss site disclosure, Commercial CDMO platform claim
CARBOGEN AMCIS is published because official company materials confirm current leadership, a real Swiss operating address, and a substantial CDMO manufacturing footprint.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Bubendorf, Switzerland
CARBOGEN AMCIS
CDMO, Drug Substance Development, Drug Product Manufacturing, Small Molecules, and Biologics · Commercial and development-stage CDMO platform
CARBOGEN AMCIS runs drug substance development, commercial manufacturing, and integrated cdmo services in Bubendorf, Switzerland.
- Lead
- Stephan Fritschi (verified ↗)
- Address
- Emdpark, 4416 Bubendorf, Switzerland (source ↗)
- Compliance
- GMP
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Commercial and development-stage CDMO platform
- Capabilities
- Drug Substance Development · Commercial Manufacturing · Integrated CDMO Services
- Founded
- 1979
- Headcount
- 501-1000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Stephan Fritschi
Chief Executive Officer
Full addressEmdpark, 4416 Bubendorf, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Commercial and development-stage CDMO platform
Bubendorf, Switzerland. CDMO, Drug Substance Development, Drug Product Manufacturing, Small Molecules, and Biologics. Review completed on 22 Mar 2026.
Swissmedic and EU pharmaceutical manufacturing oversight
Official leadership disclosure, Official Swiss site disclosure, Commercial CDMO platform claim
CDMO, Drug Substance Development, Drug Product Manufacturing, Small Molecules, and Biologics
CARBOGEN AMCIS is published because official company materials confirm current leadership, a real Swiss operating address, and a substantial CDMO manufacturing footprint.
Editorial note
CARBOGEN AMCIS is published because official company materials confirm current leadership, a real Swiss operating address, and a substantial CDMO manufacturing footprint.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Drug Substance Development
Commercial Manufacturing
Integrated CDMO Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Drug-substance development infrastructure
Commercial manufacturing systems
Analytical and quality operations
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is CARBOGEN AMCIS located?
- CARBOGEN AMCIS operates from Emdpark, 4416 Bubendorf, Switzerland, Bubendorf, Switzerland.
- Who runs CARBOGEN AMCIS?
- CARBOGEN AMCIS is led by Stephan Fritschi, Chief Executive Officer. Verified 22 Mar 2026.
- What does CARBOGEN AMCIS do?
- CARBOGEN AMCIS runs drug substance development, commercial manufacturing, and integrated cdmo services in Bubendorf, Switzerland. Core capabilities: Drug Substance Development, Commercial Manufacturing, Integrated CDMO Services.
Editorial context
Related technical briefs
Briefs that name Bubendorf as a covered market or city.